Peptide medicaments for the treatment of disease

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 13, 530324, 530325, A61K 3700, C07K 500

Patent

active

053408004

ABSTRACT:
Peptide medicaments, and antibody thereto, useful for treating or preventing diseases, particularly diseases involving an inflammatory response by a host organism against infection, that are preferably derived from the .beta. subunit, CD18, of the leukocyte integrins, and that have the property of either interfering with, or preventing undesirable leukocyte adhesion to biological materials, particular to endothelial cells, or that interfere with, or prevent the chemotaxis of leukocytes through the endothelial cell monolayer, consequently minimizing undesirable cell/tissue leukocyte binding and thus preventing or minimizing diseases resulting therefrom.

REFERENCES:
patent: 4797277 (1989-01-01), Arfors
Rudinger, Peptide Hormones (Jun. 1976) 1, 5-6.
Kishimoto et al. Cell vol. 48, 681 (Feb. 1987).
Kishimoto et al. Adv. In. Immun. vol. 46 (1989) ATIJO.
Abbas et al. Cell. & Mol. Immun (1991) at 158.
Hogg, N., 1989, Letters, pp. 111-114.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Peptide medicaments for the treatment of disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptide medicaments for the treatment of disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide medicaments for the treatment of disease will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-503120

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.